The Evaluation of Effects against Acute- or Relapse Infarction in Patients with both Diabetes and Hypertension Taking ARB and PPAR-gammma Inhibitor
Not Applicable
- Conditions
- Patients with diabetes and hypertension
- Registration Number
- JPRN-UMIN000001548
- Lead Sponsor
- HuBit genomix, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of cardiac failure 2) Diagnosis of Cardiovascular disturbance and/or cerebrovascular disease within 6 months 3) Secondary hypertension 4) Type I diabetes 5) Diagnosis and/or treatment of cancer within 5 years 6) Renal dysfunction 7) Liver dysfunction 8) History of side effects of TDZ or ARB 9) No current or past history of psychiatric disorders 10) Pregnant women or lactating mothers 11) Participating another clinical investigation within 3 months 12) Patients judged by the investigator to be unfit to be enrolled into the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary end-point is time from randomization to first occurrence of any of the events in the following composite: 1. Cardiovascular disturbance 2. Cerebrovascular disease 3. Renal failure 4. Administration of dialysis treatment 5. Cardiac mortality 6. Cerebrovascular mortality
- Secondary Outcome Measures
Name Time Method Secondary end-point is time from randomization to first occurrence of any of the events in the following composite: 1. All-cause mortality 2. Cardiac depression and impairing renal function 3. Progression of diabetes 4. Progression of hypertension